Guideline Implementation and Collaboration to Improve Diabetic Eye Care

Diabetic retinopathy (DR)/diabetic macular edema (DME) affect a majority of patients with diabetes, but appropriate management of diabetes, vision screening, and timely referral to specialty eye care can help halt progression of the disease. This collection of activities offers practical strategies clinicians can use to empower patients to engage in recommended diabetic eye care (eg, screening, risk factor), a look at the progressive nature of DR to underscore the importance of early intervention, and an overview of novel screening and diagnostic tools that can be used to expedite care.


Guideline Directed Care for Screening All Patients With Newly Diagnosed Type 2 Diabetes | 0.25 AAPA Category 1 CME credit
Missed Opportunity to Screen and Refer Early in Disease Management by Creating Guideline-Directed Care Plans | 0.25 AAPA Category 1 CME credit
Diabetic Eye Care Prime Time™ Enduring: Meeting the Guidelines Around Screening and Treatment | 0.50 AAPA Category 1 CME credit
Best Practices in Referral to Retinal Specialists: Making Sense of the Guidelines | 0.25 AAPA Category 1 CME credit
Making the Case for Early Recognition, Referral, and Treatment | 0.25 AAPA Category 1 CME credit
Best Practices for Early Recognition and Referral to Treat Suspected Diabetic Macular Edema | 0.25 AAPA Category 1 CME credit
Best Practices in Early Recognition and Referral to Evaluate NPDR | 0.25 AAPA Category 1 CME credit
DR/DME Primer: Pathophysiology, Therapies, Standards of Care Infographic | 0.25 AAPA Category 1 CME credit

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify collaborative strategies that can be used to enhance the multidisciplinary care of patients with or at risk for DR/DME to foster earlier recognition, treatment, and long-term management of DR/DME across the disease continuum
  • Recognize key factors for patient education that are needed to catalyze uptake of recommended eye care in patients with diabetes
  • Devise care plans for patients with diabetes that incorporate eye care screening in alignment with current guideline recommendations
  • Describe the natural history of DR/DME, with an emphasis on the progressive nature, which underscores the need for earlier diagnosis and treatment to prevent the development of vision-threatening complications
  • Summarize new data that demonstrate the importance of early and proactive DR/DME diagnosis and treatment, to provide the rationale for earlier referral
  • Recognize early signs of DR/DME that warrant referral, based on accurate interpretation of examination and tests, including novel imaging devices

Acknowledgement of Commercial Support

This activity is supported by an independent medical educational grant from Regeneron Pharmaceuticals, Inc.